CoChat

The Gap Between Global Tuberculosis Incidence and the First Milestone of the WHO End Tuberculosis Strategy: An Analysis Based on the Global Burden of Disease 2017 Database

Open access
Pan, Zhenyu, Zhang, Jun, Bu, Qingting, He, Hairong, Bai, Ling, Yang, Jin, Liu, Qingqing, Lyu, Jun · 2020 · Infection and Drug Resistance

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The first milestone (in 2020) of the End Tuberculosis (TB) Strategy of the World Health Organization was a 20% reduction in TB incidence rate compared with the 2015 baseline. This study aimed to determine the incidence rate of TB and how it has changed since 2015 at the global, regional, and country levels. METHODS: This study used the most recent data from the Global Burden of Disease study in 2017 to extract TB incidence rates at the global, regional, and country levels. The annual percentage change in the incidence rate (APCIR) of TB based on 2015 was calculated to evaluate the trend in the changes at various levels, including globally and at the regional and country levels. An APCIR of -4% from 2015 to 2020 is considered acceptable. RESULTS: The global APCIR was only -1.1% from 2015 to 2017. Only 2 of the 21 analyzed regions had APCIRs lower than -4%: Southern Sub-Saharan Africa and Eastern Europe. Worse still, six regions exhibited increasing TB incidence rates. At the country level, although 143 of 195 countries and territories showed reductions in TB incidence rates, the APCIR was lower than -4% in only 11 of them. CONCLUSION: This study suggests that it will be difficult to achieve the 2020 incidence rate milestone of the End Tuberculosis Strategy. This indicates the need to design and implement suitable strategies to address the current situation in order to achieve the next milestone and targets of the End Tuberculosis Strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/idr.s248875

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Changes in global TB incidence rate. Notes: The green line represents the APCIR between 2015 and 2017; the red line represents the APCIR between 2015 and 2020 in the plan of the WHO End Tuberculosis Strategy; the blue line represents the required APCIR between 2018 and 2020 in order to reach the 2020 milestone of the WHO End Tuberculosis Strategy. Abbreviations: APCIR, annual percentage change in the incidence rate.
Figure 1 Changes in global TB incidence rate. Notes: The green line represents the APCIR between 2015 and 2017; the red line represents the APCIR between 2015 and 2020 in the plan of the WHO End Tuberculosis Strategy; the blue line represents the required APCIR between 2018 and 2020 in order to reach the 2020 milestone of the WHO End Tuberculosis Strategy. Abbreviations: APCIR, annual percentage change in the incidence rate.CC BY-NC · PubMed Central
Figure 2 The APCIR of TB between 2015 and 2017 in 195 countries and territories. Abbreviation: APCIR, annual percentage change in the incidence rate.
Figure 2 The APCIR of TB between 2015 and 2017 in 195 countries and territories. Abbreviation: APCIR, annual percentage change in the incidence rate.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Szkwarko, 2019, Rhode Island Med j, 102, 47

Cited by

See all 37

Metadata

Authors
Pan, Z., Zhang, J., Bu, Q., He, H., Bai, L., Yang, J., Liu, Q., & Lyu, J.
Affiliations
  • First Affiliated Hospital of Xi'an Jiaotong University (CN)
  • Northwest Women's and Children's Hospital (CN)
Corresponding author
Lyu, Jun
Venue
Infection and Drug Resistance
Published
2020-05
Volume
Volume 13
Pages
1281-1286
ISSN
1178-6973 (ISSN-L)
OpenAlex
W3022973077
Cited by
29
References
21
Citations by year
2026: 1 · 2025: 1 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 3 · 2020: 1
FWCI
0.59
Type
journal article
Language
en
Open access
Locations
  • Infection and Drug Resistance (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
National Social Science Fund of China (16BGL183, No. 16BGL183)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
tuberculosis incidence, End TB Strategy, global burden of disease, incidence trends, regional disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.